Clinical trials involving animals can have a 99.6% failure rate in some instances sparking researchers to find alternatives

Credit: Reprocell
Credit: Reprocell

Animal-based studies have contributed to important findings and lifesaving medical advancements. The COVID-19 vaccines, for instance, were developed in animals, including mice and nonhuman primates. Animal models have also been critical in advancing AIDS drugs and in developing treatments for leukemia and other cancers, among many other uses.

But animal studies often fall short of producing useful results. They may weed out possibly effective drugs or miss toxicity in humans. They have failed to deliver breakthroughs in certain fields of medicine, including neurological conditions. A 2014 study estimated that candidate therapies for Alzheimer’s disease developed in animal models have failed in clinical trials about 99.6 percent of the time.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

A growing, multidisciplinary community of researchers around the world is investigating alternatives to animal models. Some are motivated by concerns about animal welfare, but for many, sparing the lives of millions of creatures is just an added bonus. They are driven primarily to create technologies and methods that will approximate human biology and variability better than animals do.

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1
The FDA couldn’t find a vaccine safety crisis, so it buried its own research
ChatGPT-Image-Apr-16-2026-02_56_53-PM
Financial incentives, over diagnosis, and weak oversight: Autism claims are driving up Medicare costs
Screenshot-2026-05-19-at-11.23.34-AM
West-originated vaccine disinformation sparks murders of health care workers across Africa
Screenshot-2026-05-08-at-11.55.47-AM
Anti-vax activists falsely blame COVID vaccines for the rising U.S. cancer rate among younger people.
Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe 
ChatGPT-Image-May-12-2026-11_27_01-AM-2
AI likely to improve health care, research shows—but not for blacks and ethnic minorities
ChatGPT-Image-May-7-2026-12_32_36-PM
Viewpoint: The state of U.S. vaccine policy? Dismal nationally, but some states are stepping up.
modi visit sikkim
Viewpoint: Indian PM wants farmers to switch to 50% organic. It would take at least 10 years, likely won’t work, and isn’t more sustainable
Screenshot-2026-05-18-at-12.57.12-PM
Viewpoint—‘Technology is pulling us apart’: Environmental, political, and economic
Screenshot-2026-04-13-at-1.39.26-PM
Viewpoint: ‘Safer for children?’ Stonyfield yogurt under fire for deceptive organic marketing
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.